Skip to main content
. 2017 Mar 21;123(12):2206–2218. doi: 10.1002/cncr.30589

Figure 2.

Figure 2

Pathway for treating newly diagnosed and relapsed osteosarcoma. CIVI indicates continuous intravenous infusion; CR, complete response; IE, ifosfamide and etoposide; MAP, methotrexate, doxorubicin, and cisplatin; PD, progressive disease; PR, partial response; SD, stable disease.